These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

610 related items for PubMed ID: 20691308

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Randomized comparison of everolimus-eluting and paclitaxel-eluting stents: two-year clinical follow-up from the Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients with de novo Native Coronary Artery Lesions (SPIRIT) III trial.
    Stone GW, Midei M, Newman W, Sanz M, Hermiller JB, Williams J, Farhat N, Caputo R, Xenopoulos N, Applegate R, Gordon P, White RM, Sudhir K, Cutlip DE, Petersen JL, SPIRIT III Investigators.
    Circulation; 2009 Feb 10; 119(5):680-6. PubMed ID: 19171853
    [Abstract] [Full Text] [Related]

  • 6. Long-term clinical outcomes of sirolimus- versus paclitaxel-eluting stents for patients with unprotected left main coronary artery disease: analysis of the MAIN-COMPARE (revascularization for unprotected left main coronary artery stenosis: comparison of percutaneous coronary angioplasty versus surgical revascularization) registry.
    Lee JY, Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Park SW, Park SJ.
    J Am Coll Cardiol; 2009 Aug 25; 54(9):853-9. PubMed ID: 19695467
    [Abstract] [Full Text] [Related]

  • 7. Outcomes after unrestricted use of everolimus-eluting stent compared to paclitaxel- and sirolimus-eluting stents.
    Mahmoudi M, Delhaye C, Wakabayashi K, Ben-Dor I, Gonzalez MA, Maluenda G, Gaglia MA, Torguson R, Xue Z, Suddath WO, Satler LF, Kent KM, Pichard AD, Waksman R.
    Am J Cardiol; 2011 Jun 15; 107(12):1757-62. PubMed ID: 21497782
    [Abstract] [Full Text] [Related]

  • 8. Comparison of 2-year clinical outcomes with sirolimus and paclitaxel-eluting stents for patients with diabetes: results of the Registro Regionale AngiopLastiche Emilia-Romagna Registry.
    Balducelli M, Ortolani P, Marzaroli P, Piovaccari G, Menozzi A, Manari A, Sangiorgio P, Tarantino F, Rossi R, Maresta A, Tondi S, Passerini F, Guastaroba P, Grilli R, Marzocchi A.
    Catheter Cardiovasc Interv; 2010 Feb 15; 75(3):327-34. PubMed ID: 19937776
    [Abstract] [Full Text] [Related]

  • 9. The unrestricted use of paclitaxel- versus sirolimus-eluting stents for coronary artery disease in an unselected population: one-year results of the Taxus-Stent Evaluated at Rotterdam Cardiology Hospital (T-SEARCH) registry.
    Ong AT, Serruys PW, Aoki J, Hoye A, van Mieghem CA, Rodriguez-Granillo GA, Valgimigli M, Sonnenschein K, Regar E, van der Ent M, de Jaegere PP, McFadden EP, Sianos G, van der Giessen WJ, de Feyter PJ, van Domburg RT.
    J Am Coll Cardiol; 2005 Apr 05; 45(7):1135-41. PubMed ID: 15808774
    [Abstract] [Full Text] [Related]

  • 10. Outcome in the real-world of coronary high-risk intervention with drug-eluting stents (ORCHID) -- a single-center study comparing Cypher sirolimus-eluting with Taxus paclitaxel-eluting stents.
    Kumar S, Suresh V, Prendergast BD, Brooks NH, Wicks P, Levy RD, Ray SG, Bennett DH, Lee HS.
    Catheter Cardiovasc Interv; 2006 Nov 05; 68(5):663-8. PubMed ID: 17034063
    [Abstract] [Full Text] [Related]

  • 11. In-hospital and mid-term clinical outcomes after percutaneous coronary intervention with the use of sirolimus- or paclitaxel-eluting stents.
    Alidoosti M, Salarifar M, Kassaian SE, Zeinali AM, Nematipoor E, Sheikhfathollahi M, Poorhosseini H, Dehkordi MR, Abbasi A.
    Kardiol Pol; 2009 Dec 05; 67(12):1344-50. PubMed ID: 20054765
    [Abstract] [Full Text] [Related]

  • 12. Clinical efficacy of drug-eluting stents in diabetic patients: a meta-analysis.
    Mahmud E, Bromberg-Marin G, Palakodeti V, Ang L, Creanga D, Demaria AN.
    J Am Coll Cardiol; 2008 Jun 24; 51(25):2385-95. PubMed ID: 18565394
    [Abstract] [Full Text] [Related]

  • 13. Comparison of six-year clinical outcome of sirolimus- and paclitaxel-eluting stents to bare-metal stents in patients with ST-segment elevation myocardial infarction: an analysis of the RESEARCH (rapamycin-eluting stent evaluated at Rotterdam cardiology hospital) and T-SEARCH (taxus stent evaluated at Rotterdam cardiology hospital) registries.
    Simsek C, Magro M, Boersma E, Onuma Y, Nauta S, Daemen J, Gaspersz M, van Geuns RJ, van der Giessen W, van Domburg R, Serruys P.
    J Invasive Cardiol; 2011 Aug 24; 23(8):336-41. PubMed ID: 21828397
    [Abstract] [Full Text] [Related]

  • 14. Comparison of three-year clinical outcome of sirolimus- and paclitaxel-eluting stents versus bare metal stents in patients with ST-segment elevation myocardial infarction (from the RESEARCH and T-SEARCH Registries).
    Daemen J, Tanimoto S, García-García HM, Kukreja N, van de Sande M, Sianos G, de Jaegere PP, van Domburg RT, Serruys PW.
    Am J Cardiol; 2007 Apr 15; 99(8):1027-32. PubMed ID: 17437722
    [Abstract] [Full Text] [Related]

  • 15. Long-term clinical outcomes and stent thrombosis of sirolimus-eluting versus bare metal stents in patients with end-stage renal disease: results of Korean multicenter angioplasty team (KOMATE) Registry.
    Kim BK, Oh S, Jeon DW, Yang JY, Kim JS, Park S, Choi D, Jang Y, Hong BK, Kwon HM, Lee SW, Goh CW, Kwon K, Ryu SK, Korean Multicenter Angioplasty Team (KOMATE) Investigators.
    J Interv Cardiol; 2009 Oct 15; 22(5):411-9. PubMed ID: 19702679
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Very late coronary stent thrombosis of a newer-generation everolimus-eluting stent compared with early-generation drug-eluting stents: a prospective cohort study.
    Räber L, Magro M, Stefanini GG, Kalesan B, van Domburg RT, Onuma Y, Wenaweser P, Daemen J, Meier B, Jüni P, Serruys PW, Windecker S.
    Circulation; 2012 Mar 06; 125(9):1110-21. PubMed ID: 22302840
    [Abstract] [Full Text] [Related]

  • 19. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA, Akin I, Schneider S, Senges J, Fetsch T, Tebbe U, Willich SN, Stumpf J, Sabin GV, Silber S, Richardt G, Kuck KH, DES.DE Study Group.
    Am J Cardiol; 2009 Nov 15; 104(10):1362-9. PubMed ID: 19892051
    [Abstract] [Full Text] [Related]

  • 20. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
    Akin I, Bufe A, Eckardt L, Reinecke H, Richardt G, Kuck KH, Senges J, Schneider S, Nienaber CA, DES.DE Study Group.
    Catheter Cardiovasc Interv; 2010 Jul 01; 76(1):50-7. PubMed ID: 20578192
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 31.